Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?
Nutrition, Metabolism and Cardiovascular Diseases · 2026-12 · 36 (12) · 104860
DOI: 10.1016/j.numecd.2026.104860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-12. Verfasst von Sabrina Scilletta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Hyperuricemia, Gout, Obesity, Weight Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
AIMS: Hyperuricemia-elevated serum uric acid (SUA)-is the pathogenic driver of gout and is recognized as a systemic condition associated with cardiometabolic risk, including cardiovascular disease and type 2 diabetes, although causality remains debated. Its global prevalence has risen substantially over decades, paralleling the growing epidemic of obesity and increasing life expectancy. This narrative review examines the relationship between adiposity and hyperuricemia and summarises the knowledge about the impact of weight-loss interventions on SUA levels and gout risk. DATA SYNTHESIS: Epidemiological evidence supports a bidirectional relationship between adiposity and hyperuricemia, although Mendelian randomisation studies suggest that excess adiposity is likely a cause rather than consequence of elevated SUA. Multiple mechanisms may underlie this association, including insulin resistance, reduced renal urate excretion, visceral adiposity, and dietary factors. Weight reduction is now recommended as a cornerstone of hyperuricemia and gout management in individuals with overweight or obesity. Lifestyle and dietary interventions are associated with modest reductions in SUA and gout risk. Bariatric surgery achieves substantial and sustained weight loss, leading to significant long-term reductions of SUA and gout incidence, despite a transient postoperative SUA increase. Recently, pharmacological weight-loss therapies (i.e. glucagon-like peptide-1 receptor agonists and tirzepatide) demonstrated meaningful reductions in SUA levels, potentially largely mediated by weight loss. CONCLUSIONS: Integrating obesity management into hyperuricemia care represents a key strategy to reduce gout incidence and flares. Further research evaluating emerging anti-obesity therapies impact on hyperuricemia-specific outcomes would be useful, perhaps particularly in people experiencing ongoing flares despite other therapies and with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Department of Medicine and Surgery, "Kore" University of Enna, Enna, 94100, Italy.
- Endocrine Unit, Garibaldi-Nesima Hospital, Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Electronic address: salvatore.piro@unict.it.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.
Zitieren
APA
Scilletta, S., Di Marco, M., Bosco, G., Di Giacomo Barbagallo, F., Galeano, F., Tumminia, A., Milluzzo, A., Gaudio, A., Frittitta, L., Scicali, R., Castellino, P., Piro, S., Sattar, N., & Di Pino, A. (2026). Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?. Nutrition, Metabolism and Cardiovascular Diseases, 36(12), 104860. https://doi.org/10.1016/j.numecd.2026.104860
Vancouver
Scilletta S, Di Marco M, Bosco G, Di Giacomo Barbagallo F, Galeano F, Tumminia A, et al. Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(12):104860. doi:10.1016/j.numecd.2026.104860
BibTeX
@article{Scilletta2026,
author = {Scilletta, Sabrina and Di Marco, Maurizio and Bosco, Giosiana and Di Giacomo Barbagallo, Francesco and Galeano, Francesco and Tumminia, Andrea and Milluzzo, Agostino and Gaudio, Agostino and Frittitta, Lucia and Scicali, Roberto and Castellino, Pietro and Piro, Salvatore and Sattar, Naveed and Di Pino, Antonino},
title = {Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {12},
pages = {104860},
doi = {10.1016/j.numecd.2026.104860}
}
EUVIMED